Mark Mulvahill

Mark Mulvahill is a Senior Director and Microbiology Unit Lead at the United States Pharmacopeia (USP) and co-founder of Stratix Labs, where they previously served as Chief Executive Officer. Mark has experience in evaluating commercial opportunities for new technologies and has founded several companies, including Loewi LLC, which developed intellectual property for novel drug delivery technologies. As a Fulbright scholar, Mark focused on antimicrobial drug discovery and holds a Master of Science degree in Chemistry, an MBA with a specialization in healthcare, and a Bachelor of Arts in Biology. They are also a registered patent agent with the USPTO.